Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

Ludovic C. Dormegny-Jeanjean; Clément de Crespin de Billy; Olivier Mainberger; Sébastien Weibel; Benoît Schorr; Alexandre Obrecht; Lionel Landré; Fabrice Berna; Jean-Baptiste Causin; Frédéric Blanc; Vlad Dănilă; Mihaela Tomsa; Geraldine Pfleger; Camille Meyer; Ilia Humbert; Hervé Javelot; Guillaume Meyer; Gilles Bertschy; Jack Foucher

doi:10.3389/fpsyt.2023.1194090

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

These results support TRAD sensitivity to pro-dopaminergic interventions. However, some clinical heterogeneities remain in our sample and suggest some improvement in the description of dopamine-sensitive form(s).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dormegny-Jeanjean et al. (2023) studied this question.

synapsesocial.com/papers/69d975a72a25b240b7a3c551 https://doi.org/10.3389/fpsyt.2023.1194090

View Full Paper

Ask AI

Bookmark

Share

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

Ask about this paper

Abstract

Discussion

Cite This Study

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading